Huo TI - Search Results

1

Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.

Hsu CY, Liu PH, Ho SY, Huang YH, Lee YH, Chiou YY, Hsieh TH, Fang T, Tsai YJ, Hou MC, Huo TI. Hsu CY, et al. Among authors: huo ti. PLoS One. 2017 Nov 10;12(11):e0188031. doi: 10.1371/journal.pone.0188031. eCollection 2017. PLoS One. 2017. PMID: 29125877 Free PMC article.

2

Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Scand J Gastroenterol. 2002 Mar;37(3):350-5. doi: 10.1080/003655202317284273. Scand J Gastroenterol. 2002. PMID: 11916199

3

Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan.

Su CW, Wu JC, Huang YS, Huo TI, Huang YH, Lin CC, Chang FY, Lee SD. Su CW, et al. Among authors: huo ti. J Gastroenterol Hepatol. 2002 Nov;17(11):1187-91. doi: 10.1046/j.1440-1746.2002.02858.x. J Gastroenterol Hepatol. 2002. PMID: 12453278

4

Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection.

Huo TI, Wu JC, Lui WY, Lee PC, Huang YH, Chau GY, Tsay SH, Chang FY, Lee SD. Huo TI, et al. Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1203-8. doi: 10.1097/00042737-200311000-00009. Eur J Gastroenterol Hepatol. 2003. PMID: 14560154

5

Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study.

Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Am J Gastroenterol. 2003 Oct;98(10):2293-8. doi: 10.1111/j.1572-0241.2003.07688.x. Am J Gastroenterol. 2003. PMID: 14572582

6

Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations.

Huo TI, Wu JC, Wu SI, Chang AL, Lin SK, Pan CH, Huang YH, Chang FY, Lee SD. Huo TI, et al. J Med Virol. 2004 Jan;72(1):41-5. doi: 10.1002/jmv.10554. J Med Virol. 2004. PMID: 14635009

7

Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.

Huo TI, Huang YH, Lui WY, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Oncol Rep. 2004 Feb;11(2):543-50. Oncol Rep. 2004. PMID: 14719097

8

Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.

Huo TI, Lui WY, Wu JC, Huang YH, King KL, Loong CC, Lee PC, Chang FY, Lee SD. Huo TI, et al. World J Surg. 2004 Mar;28(3):258-62. doi: 10.1007/s00268-003-7182-6. Epub 2004 Feb 17. World J Surg. 2004. PMID: 14961198

9

Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.

Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Liver Int. 2004 Jun;24(3):210-5. doi: 10.1111/j.1478-3231.2004.00911.x. Liver Int. 2004. PMID: 15189271

10

Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Eur J Gastroenterol Hepatol. 2004 Mar;16(3):325-31. doi: 10.1097/00042737-200403000-00013. Eur J Gastroenterol Hepatol. 2004. PMID: 15195898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters